摘要:
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt, ester or stereoisomer thereof, wherein R1 to R3 and X have the significances given herein. The present invention is also directed to processes for making said compounds and uses of said compounds, in particular their use as medicaments, more particularly their use as medicaments in the treatment of cancer.
摘要:
A method for charging for a service is provided. The method includes: receiving, by a data service management device, submitted current communication service scenario information of a user; searching, by the data service management device, for priority information of charging in an account of the user, in a mapping relation between a communication service scenario and a charging priority of the account, according to the received current communication service scenario information of the user; pricing, in the account of the user according to the found priority information, and submitting a priced result to an intelligence network; and charging, by the intelligence network, the account of the user sequentially according to the submitted priced result. A device and a system for charging for a service, and a service management device are also provided.
摘要:
A method for user equipment acquiring a multicast program address includes: receiving, via a Short Massage Service Center (SMSC), an updating program bookmark message containing a multicast program address from an Over The Air (OTA); acquiring the multicast program address from the updating program bookmark message. The present invention also provides a system and an apparatus for user equipment to acquire a multicast program address. With the solution of the present invention, the UE may acquire the multicast program address without network connecting.
摘要:
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt, ester or stereoisomer thereof, wherein R1 to R3 and X have the significances given herein. The present invention is also directed to processes for making said compounds and uses of said compounds, in particular their use as medicaments, more particularly their use as medicaments in the treatment of cancer.